JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Interest Expense Over TimeContracting
Percentile Rank50
3Y CAGR+18.2%
5Y CAGR+3.8%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+18.2%/yr
vs -15.4%/yr prior
5Y CAGR
+3.8%/yr
Recent acceleration
Acceleration
+33.6pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$2.40B-11.8%
2024$2.72B+44.7%
2023$1.88B+29.4%
2022$1.45B-21.0%
2021$1.84B-7.8%
2020$2.00B-8.6%
2019$2.19B-22.9%
2018$2.83B-16.7%
2017$3.40B-8.3%
2016$3.71B-